Egyptian Int'l Pharmaceutical Industries Stock Egyptian Exchange
Stocks
Pharmaceuticals
|
End-of-day quote
Egyptian Exchange
|
||
| - EGP | - |
|
| Market Cap | 21.4B 417M 359M 340M 308M 578M 39.83B 581M 4.04B 1.55B 20.26B 1.57B 1.53B 64.03B | P/E 2026 * |
18.8x | P/E 2027 * | 12.8x |
|---|---|---|---|---|---|
| Enterprise Value | 29.99B 584M 503M 477M 432M 811M 55.83B 815M 5.66B 2.18B 28.4B 2.19B 2.15B 89.75B | EV / Sales 2026 * |
2.81x | EV / Sales 2027 * | 2.34x |
| Free-Float |
35.11% | Yield 2026 * |
2.56% | Yield 2027 * | 3.31% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
Khaled Mahmoud
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.13% | -3.11% | +14.31% | +61.84% | 46.21B | |
| -1.13% | -5.78% | +34.89% | +111.91% | 38.78B | |
| +0.12% | -0.08% | +7.23% | +78.04% | 11.68B | |
| -0.53% | -1.37% | -12.48% | +9.51% | 11.55B | |
| -0.38% | -2.26% | +18.18% | +136.36% | 9.14B | |
| +0.32% | -2.26% | +23.33% | +33.23% | 7.3B | |
| -1.00% | -5.25% | +33.87% | -18.63% | 7.1B | |
| +0.17% | -0.74% | +13.70% | +198.32% | 7.15B | |
| -3.13% | -4.30% | -44.48% | +13.47% | 4.97B | |
| Average | -0.74% | -2.59% | +9.84% | +69.34% | 15.99B | |
| Weighted average by Cap. | -0.86% | -3.27% | +16.74% | +76.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.67B 208M 179M 170M 154M 288M 19.86B 290M 2.01B 775M 10.11B 781M 764M 31.93B | 12.45B 243M 209M 198M 179M 337M 23.18B 338M 2.35B 904M 11.79B 911M 891M 37.27B |
| Net income | 1.23B 24.05M 20.73M 19.62M 17.79M 33.37M 2.3B 33.54M 233M 89.63M 1.17B 90.34M 88.36M 3.69B | 1.85B 36.14M 31.13M 29.48M 26.72M 50.13M 3.45B 50.38M 350M 135M 1.76B 136M 133M 5.55B |
| Net Debt | 8.59B 167M 144M 137M 124M 232M 15.99B 233M 1.62B 624M 8.14B 629M 615M 25.71B | 7.78B 152M 131M 124M 112M 210M 14.49B 211M 1.47B 565M 7.37B 570M 557M 23.29B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
